LobbyingComplete Genomics lobbying by quarter
Complete Genomics's latest lobbying report covers Q4 2025, at $80K. The four quarters Q4 2025–Q3 2026 total $80K. Its first report covers Q3 2023; the issues it reports most are Defense and Medical/Disease Research/Clinical Labs.
Complete Genomics
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $80K
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q3 2023
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q3 2023 | $150K | 1 |
| Q4 2023 | $300K | 2 |
| Q1 2024 | $350K | 3 |
| Q2 2024 | $330K | 2 |
| Q3 2024 | $310K | 2 |
| Q4 2024 | $290K | 2 |
| Q1 2025 | $80K | 1 |
| Q2 2025 | $80K | 1 |
| Q3 2025 | $80K | 1 |
| Q4 2025 | $80K | 1 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Defense$1.8M · 16 reports
- Medical research and clinical labs$300K · 4 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES16 reports
- SENATE16 reports
Firms it paid
| Firm | ||
|---|---|---|
| Avoq | $1.1M | 9 quarters |
| CLS Strategies | $600K | 4 quarters |
| The Vogel Group | $400K | 3 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| JAMES KA CHUN LAI | Former Staff Assistant, Senate Energy and Natural Resources Committee | Q1 2024 |
| SAMIR N KAPADIA | Former Government Relations Staffer, The Heritage Foundation | Q4 2023 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 06/29for Q1 2024 | The Vogel Group | $100K |
| 06/29for Q4 2023 | The Vogel Group | $150K |
| 06/29for Q3 2023 | The Vogel Group | $150K |
| 01/20for Q4 2025 | Avoq | $80K |
| 25/10/20for Q3 2025 | Avoq | $80K |
| 25/07/21for Q2 2025 | Avoq | $80K |
| 25/04/21for Q1 2025 | Avoq | $80K |
| 25/01/21for Q4 2024 | Avoq | $130K |
| 25/01/06for Q4 2024 | CLS Strategies | $160K |
| 24/10/21for Q3 2024 | CLS Strategies | $160K |
| 24/10/21for Q3 2024 | Avoq | $150K |
| 24/07/23for Q2 2024 | CLS Strategies | $180K |
| 24/07/22for Q2 2024 | Avoq | $150K |
| 24/04/22for Q1 2024 | CLS Strategies | $100K |
| 24/04/22for Q1 2024 | Avoq | $150K |
| 24/04/19for Q1 2024 | The Vogel Group | $100K |
| 24/03/23for Q1 2024 | CLS Strategies | Under $5,000 |
| 24/02/21for Q1 2024 | The Vogel Group | $150K |
| 24/01/22for Q4 2023 | Avoq | $150K |
| 24/01/19for Q4 2023 | The Vogel Group | $150K |